COVID-19 and Panax ginseng: Targeting platelet aggregation, thrombosis and the coagulation pathway

Hamming, 2004, Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J Pathol, 203, 631, 10.1002/path.1570 Gallagher, 2008, Regulation of ACE2 in cardiac myocytes and fibroblasts, Am J Physiol Heart Circ Physiol, 295, H2373, 10.1152/ajpheart.00426.2008 Santos, 2018, The ACE2/angiotensin-(1–7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1–7), Physiol Rev, 98, 503, 10.1152/physrev.00023.2016 Gupta, 2020, Extrapulmonary manifestations of COVID-19, Nat Med, 26, 1017, 10.1038/s41591-020-0968-3 Zhang, 2020, SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19, J Hematol Oncol, 13, 120, 10.1186/s13045-020-00954-7 Manne, 2020, Platelet gene expression and function in patients with COVID-19, Blood, 136, 1317, 10.1182/blood.2020007214 Zaid, 2020, Platelets can contain SARS-CoV-2 RNA and are hyperactivated in COVID-19, Circ Res, 127, 1404, 10.1161/CIRCRESAHA.120.317703 Shen, 2020, Proteomic and metabolomic characterization of COVID-19 patient sera, Cell, 182, 59, 10.1016/j.cell.2020.05.032 Wichmann, 2020, Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study, Ann Intern Med, 173, 268, 10.7326/M20-2003 Vulliamy, 2020, Acute aorto-iliac and mesenteric arterial thromboses as presenting features of COVID-19, Br J Haematol, 189, 1053, 10.1111/bjh.16760 Xu, 2020, Pathological changes of the spleen in ten patients with new coronavirus infection by minimally invasive autopsies, Chin J Pathol, 49, 576 Klok, 2020, Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis, Thromb Res, 191, 148, 10.1016/j.thromres.2020.04.041 Middeldorp, 2020, Incidence of venous thromboembolism in hospitalized patients with COVID-19, J Thromb Haemostasis, 18, 1995, 10.1111/jth.14888 Peerschke, 2010, Complement activation on platelets: implications for vascular inflammation and thrombosis, Mol Immunol, 47, 2170, 10.1016/j.molimm.2010.05.009 Jackson, 2019, Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms, Blood, 133, 906, 10.1182/blood-2018-11-882993 Hanff, 2020, Thrombosis in COVID-19, Am J Hematol, 95, 1578, 10.1002/ajh.25982 Tang, 2020, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, J Thromb Haemostasis, 18, 844, 10.1111/jth.14768 Cipolloni, 2020, Preliminary post-mortem COVID-19 evidence of endothelial injury and factor VIII hyperexpression, Diagnostics, 10, 575, 10.3390/diagnostics10080575 Nuyttens, 2011, Platelet adhesion to collagen, Thromb Res, 127, S26, 10.1016/S0049-3848(10)70151-1 van Gils, 2009, Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases, J Leukoc Biol, 85, 195, 10.1189/jlb.0708400 Nicolai, 2019, Platelets in host defense: experimental and clinical insights, Trends Immunol, 40, 922, 10.1016/j.it.2019.08.004 Stocker, 2017, Small but mighty: platelets as central effectors of host defense, Thromb Haemostasis, 117, 651, 10.1160/TH16-12-0921 Newby, 2009, Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes, Thromb Haemostasis, 101, 1006, 10.1160/TH08-07-0469 Bobryshev, 2006, Monocyte recruitment and foam cell formation in atherosclerosis, Micron, 37, 208, 10.1016/j.micron.2005.10.007 Thim, 2008, From vulnerable plaque to atherothrombosis, J Intern Med, 263, 506, 10.1111/j.1365-2796.2008.01947.x Longstaff, 2018, Measuring fibrinolysis: from research to routine diagnostic assays, J Thromb Haemostasis, 16, 652, 10.1111/jth.13957 Wright, 2020, Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 infection, J Am Coll Surg, 231, 193, 10.1016/j.jamcollsurg.2020.05.007 Medcalf, 2020, Fibrinolysis and COVID-19: a plasmin paradox, J Thromb Haemostasis, 18, 2118, 10.1111/jth.14960 Ibañez, 2021, High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?, J Thromb Thrombolysis, 51, 308, 10.1007/s11239-020-02226-0 Schmitt, 2019, Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study, Ann Intensive Care, 9, 19, 10.1186/s13613-019-0499-6 Olwal, 2021, Parallels in sepsis and COVID-19 conditions: implications for managing severe COVID-19 patients, Front Immunol, 12, 602848, 10.3389/fimmu.2021.602848 Mokhtari, 2020, COVID-19 and multiorgan failure: a narrative review on potential mechanisms, J Mol Histol, 51, 613, 10.1007/s10735-020-09915-3 Cerletti, 2012, Platelet-leukocyte interactions in thrombosis, Thromb Res, 129, 263, 10.1016/j.thromres.2011.10.010 Lishko, 2004, Multiple binding sites in fibrinogen for integrin αMβ2 (Mac-1), J Biol Chem, 279, 44897, 10.1074/jbc.M408012200 Wagner, 1995, P-selectin chases a butterfly, J Clin Invest, 95, 1955, 10.1172/JCI117878 Koupenova, 2018, Circulating platelets as mediators of immunity, inflammation, and thrombosis, Circ Res, 122, 337, 10.1161/CIRCRESAHA.117.310795 Hottz, 2020, Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19, Blood, 136, 1330, 10.1182/blood.2020007252 Le Joncour, 2020, Neutrophil–platelet and monocyte–platelet aggregates in COVID-19 patients, Thromb Haemostasis, 120, 1733, 10.1055/s-0040-1718732 Leppkes, 2020, Vascular occlusion by neutrophil extracellular traps in COVID-19, EBioMedicine, 58, 102925, 10.1016/j.ebiom.2020.102925 Falati, 2003, Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin, J Exp Med, 197, 1585, 10.1084/jem.20021868 Fuzimoto, 2020, The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds-Additional weapons in the fight against the COVID-19 pandemic?, J Tradit Complement Med, 10, 405, 10.1016/j.jtcme.2020.05.003 Singh, 2021, Spices and herbs: potential antiviral preventives and immunity boosters during COVID-19, Phytother Res, 35, 2745, 10.1002/ptr.7019 Panyod, 2020, Dietary therapy and herbal medicine for COVID-19 prevention: a review and perspective, J Tradit Complement Med, 10, 420, 10.1016/j.jtcme.2020.05.004 Ang, 2020, Herbal medicine for the management of COVID-19 during the medical observation period: a review of guidelines, Integr Med Res, 9, 100465, 10.1016/j.imr.2020.100465 Shahzad, 2020, The antiviral, anti-inflammatory effects of natural medicinal herbs and mushrooms and SARS-CoV-2 infection, Nutrients, 12, 2573, 10.3390/nu12092573 Korkmaz, 2021, Could sumac be effective on COVID-19 treatment?, J Med Food, 24, 563, 10.1089/jmf.2020.0104 Gautam, 2022, Immunity against COVID-19: potential role of Ayush Kwath, J Ayurveda Integr Med, 13, 100350, 10.1016/j.jaim.2020.08.003 Smeda, 2020, Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter?, Cardiovasc Res, 116, e118, 10.1093/cvr/cvaa190 Jeong, 2017, Ginsenoside Rg3-enriched red ginseng extract inhibits platelet activation and in vivo thrombus formation, J Ginseng Res, 41, 548, 10.1016/j.jgr.2016.11.003 Irfan, 2018, Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling, Vasc Pharmacol, 109, 45, 10.1016/j.vph.2018.06.002 Irfan, 2019, Gintonin modulates platelet function and inhibits thrombus formation via impaired glycoprotein VI signaling, Platelets, 30, 589, 10.1080/09537104.2018.1479033 Barrett, 2021, Platelets amplify endotheliopathy in COVID-19, Sci Adv, 7, 10.1126/sciadv.abh2434 Barrett, 2021, Platelets contribute to disease severity in COVID-19, J Thromb Haemostasis, 19, 3139, 10.1111/jth.15534 Irfan, 2020, Anti-platelet role of Korean ginseng and ginsenosides in cardiovascular diseases, J Ginseng Res, 44, 24, 10.1016/j.jgr.2019.05.005 Irfan, 2020, Adaptogenic effects of Panax ginseng on modulation of cardiovascular functions, J Ginseng Res, 44, 538, 10.1016/j.jgr.2020.03.001 Lee, 2021, Panax ginseng: inflammation, platelet aggregation, thrombus formation, and atherosclerosis crosstalk, J Ginseng Res Shin, 2017, Inhibitory effects of total saponin Korean red ginseng on thromboxane A 2 production and P-selectin expression via suppressing mitogen-activated protein kinases, Biomed Sci Letters, 23, 310, 10.15616/BSL.2017.23.4.310 Kwon, 2015, Inhibitory effects of cytosolic Ca(2+) concentration by ginsenoside Ro are dependent on phosphorylation of IP3RI and dephosphorylation of ERK in human platelets, Evid Based Complement Alternat Med, 2015, 764906, 10.1155/2015/764906 Cho, 2018, Ginseng berry extract increases nitric oxide level in vascular endothelial cells and improves cGMP expression and blood circulation in muscle cells, J Exerc Nutrition Biochem, 22, 6, 10.20463/jenb.2018.0018 Zheng, 2020, COVID-19 and the cardiovascular system, Nat Rev Cardiol, 17, 259, 10.1038/s41569-020-0360-5 Lacour, 2021, Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients, Cathet Cardiovasc Interv, 97, E241, 10.1002/ccd.28948 Son, 2017, The inhibitory activity of ginsenoside Rp4 in adenosine diphosphate-induced platelet aggregation, J Ginseng Res, 41, 96, 10.1016/j.jgr.2016.01.003 Shin, 2021, Ginsenoside Rk1 suppresses platelet mediated thrombus formation by downregulation of granule release and αIIbβ3 activation, J Ginseng Res, 45, 490, 10.1016/j.jgr.2020.11.001 Jeon, 2015, The inhibitory mechanism of crude saponin fraction from Korean Red Ginseng in collagen-induced platelet aggregation, J Ginseng Res, 39, 279, 10.1016/j.jgr.2015.02.001 Endale, 2012, Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation, Br J Pharmacol, 167, 109, 10.1111/j.1476-5381.2012.01967.x Irfan, 2021, Comparative antiplatelet and antithrombotic effects of red ginseng and fermented red ginseng extracts, J Ginseng Res, 10.1016/j.jgr.2021.05.010 Durrant, 2017, Integrin αIIbβ3 outside-in signaling, Blood, 130, 1607, 10.1182/blood-2017-03-773614 Shattil, 1998, Integrin signaling: the platelet paradigm, Blood, 91, 2645, 10.1182/blood.V91.8.2645.2645_2645_2657 Dhawan, 2021, Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19, Lancet Respir Med, 9, 107, 10.1016/S2213-2600(20)30407-0 Willyard, 2020, Coronavirus blood-clot mystery intensifies, Nature, 581, 250, 10.1038/d41586-020-01403-8 Price, 2020, Thrombosis and COVID-19 pneumonia: the clot thickens, Eur Respir J, 56, 2001608, 10.1183/13993003.01608-2020 Al-Hakeim, 2021 Conti, 2020, IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra), J Biol Regul Homeost Agents, 34, 1623 Sangkuhl, 2011, Platelet aggregation pathway, Pharmacogenetics Genom, 21, 516, 10.1097/FPC.0b013e3283406323 Pelzl, 2021, Antibody-mediated procoagulant platelet formation in COVID-19 is AKT dependent, J Thromb Haemost Basile, 2021, The PI3K/Akt/mTOR pathway: a potential pharmacological target in COVID-19, Drug Discov Today, S1359–6446, 480 Abu-Eid, 2021, Targeting the PI3K/Akt/mTOR pathway: a therapeutic strategy in COVID-19 patients, Immunol Lett, 240, 1, 10.1016/j.imlet.2021.09.005 Kohl, 2011, Cytoscape: software for visualization and analysis of biological networks, Methods Mol Biol, 696, 291, 10.1007/978-1-60761-987-1_18 Doncheva, 2019, Cytoscape StringApp: network analysis and visualization of proteomics data, J Proteome Res, 18, 623, 10.1021/acs.jproteome.8b00702 Abu-Farha, 2020, Prognostic genetic markers for thrombosis in COVID-19 patients: a focused analysis on D-dimer, homocysteine and thromboembolism, Front Pharmacol, 11, 587451, 10.3389/fphar.2020.587451 Dong, 2002, ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions, Blood, 100, 4033, 10.1182/blood-2002-05-1401 Chauhan, 2008, ADAMTS13: a new link between thrombosis and inflammation, J Exp Med, 205, 2065, 10.1084/jem.20080130 Mulder, 2017, SERPINC 1 gene mutations in antithrombin deficiency, Br J Haematol, 178, 279, 10.1111/bjh.14658 Ru, 2014, TCMSP: a database of systems pharmacology for drug discovery from herbal medicines, J Cheminf, 6, 13 Liu, 2016, BATMAN-TCM: a bioinformatics analysis tool for molecular mechANism of traditional Chinese medicine, Sci Rep, 6, 21146, 10.1038/srep21146 Kim, 2021, A network pharmacology approach to explore the potential role of Panax ginseng on exercise performance, Phys Act Nutr, 25, 28, 10.20463/pan.2021.0018 Liu, 2020, Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19, Acta Pharm Sin B, 10, 1205, 10.1016/j.apsb.2020.04.008 Mohamed-Hussein, 2020, Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?, Med Hypotheses, 144, 109975, 10.1016/j.mehy.2020.109975 Meizlish, 2021, Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis, Am J Hematol, 96, 471, 10.1002/ajh.26102 Osborne, 2021, Association of mortality and aspirin prescription for COVID-19 patients at the Veterans Health Administration, PLoS One, 16, 10.1371/journal.pone.0246825 Salah, 2021, Meta-analysis of the effect of aspirin on mortality in COVID-19, Am J Cardiol, 142, 158, 10.1016/j.amjcard.2020.12.073 Moroni, 2021, COVID-19 and arterial thrombosis: a potentially fatal combination, Int J Cardiol, 322, 286, 10.1016/j.ijcard.2020.10.046